After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.
Zoetis is selling a lineup of drugs for dogs, and that looks to mean big business.
Zoetis is not averse to a little noise as investors, analysts take notice.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.